1.
Pulczynski EJ, Kuittinen O, Erlanson M, Hagberg H, Fosså A, Eriksson M, Nordstrøm M, Østenstad B, Fluge Øystein, Leppä S, Fiirgaard B, Bersvendsen H, Fagerli U-M. Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group. Haematologica 2015; 100(4):534-540; https://doi.org/10.3324/haematol.2014.108472.